Tofersen as promising therapeutic option for ALS. Results from phase 1 show treatment is safe and tolerable. Responder/non-responder analysis should be interpreted with caution. Interesting decline in neurofilament and late stage clinical trial is indicated #alsmndsymppic.twitter.com/dtsNYJuJfJ
20:40 - 3. pro 2019.
0 replies
8 proslijeđenih tweetova
12 korisnika označava da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.